Among them, Interleukin (IL)-30, which has been found to be expressed by cancer and/or infiltrating myeloid cells, in approximately 77% of metastatic PC, correlates with high-grade and stage of the disease [3] and has been reported to promote PC onset and progression in immunocompetent murine models [4]. This evidence concerns the gene IL27 and pachyonychia congenita.